Dianthus Therapeutics
DNTH
DNTH
94 hedge funds and large institutions have $217M invested in Dianthus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 16 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 95 → 94 (-1)
12% less capital invested
Capital invested by funds: $248M → $217M (-$30.4M)
97% less call options, than puts
Call options by funds: $3K | Put options by funds: $89K
Holders
94
Holding in Top 10
2
Calls
$3K
Puts
$89K
Top Buyers
| 1 | +$6.52M | |
| 2 | +$1.27M | |
| 3 | +$1.19M | |
| 4 |
BlackRock
New York
|
+$1.13M |
| 5 |
Renaissance Technologies
New York
|
+$1.04M |
Top Sellers
| 1 | -$4.51M | |
| 2 | -$3.38M | |
| 3 | -$3.38M | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$3.11M |
| 5 |
LM
Luminus Management
Houston,
Texas
|
-$2.7M |